EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient Perceptions of a Preventive Effect of Long-Term Botulinum Neurotoxin Therapy in Cervical Dystonia

Harald Hefter iD, Sara Samadzadeh iD

Toxins · 12.04.2026 · 18 (4) · 184

DOI: 10.3390/toxins18040184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, online erschienen am 12.04.2026. Verfasst von Harald Hefter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Düsseldorf, Moorenstrasse 5, D-40225 Düsseldorf, Germany. Hauptthemen laut MEDLINE: Torticollis, Botulinum Toxins. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with cervical dystonia (CD) often believe that disease severity would have progressed beyond the pre-treatment level if botulinum neurotoxin (BoNT) therapy had not been initiated. The aim of the present study was to assess the perceptions of long-term BoNT-treated patients with CD regarding the expected course of disease severity over the next 10 years under the hypothetical assumption that BoNT therapy is discontinued. Fifty patients with idiopathic CD receiving long-term BoNT therapy were screened, and 43 patients were included. Disease severity at the day of recruitment was assessed as a percentage of CD severity at the onset of BoNT therapy (PAS-%). Patients also generated, in a standardized manner, a graph illustrating the development of CD severity since initiation of BoNT therapy. Subsequently, patients estimated the expected severity of CD after 10 years, expressed as a percentage of severity at BoNT therapy onset (PAS-STD), under the hypothetical assumption that BoNT therapy was discontinued at the time of recruitment. They additionally drew a graph depicting the anticipated progression of CD severity over the subsequent 10 years under this assumption. Furthermore, 33 of these 43 patients had previously assessed the expected development of CD severity under the assumption that no BoNT therapy had ever been performed (PAS-NO%) in an earlier study. Mean PAS-STD was significantly higher than mean PAS-% (p < 0.001). Comparison of mean PAS-STD with mean PAS-NO% in the 33 patients who participated in both studies demonstrated that mean PAS-STD was significantly lower than mean PAS-NO% (p < 0.001). Long-term BoNT-treated patients with CD believe that disease severity would worsen again if BoNT therapy were discontinued. However, they do not expect CD severity to deteriorate to the level that they believe would have been reached if no BoNT therapy had been administered. We interpret this finding as suggesting that patients perceive a preventive effect of long-term BoNT therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TorticollisBotulinum ToxinsHumansFemaleMiddle AgedMaleAgedSeverity of Illness IndexDisease ProgressionAdultPerceptionTreatment Outcome

Stichwörter der Autor:innen

botulinum neurotoxincervical dystoniadisease progressionillness perceptionlong-term therapypatient perceptionpatient-reported outcomespreventive effect

Substanzen

Botulinum Toxins

Autor:innen und Institutionen

  • Department of Neurology, University of Düsseldorf, Moorenstrasse 5, D-40225 Düsseldorf, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Unverstät zu Berlin, Experimental and Clinical Research Center, D-13125 Berlin, Germany.

ORCID-Profile: Harald Hefter, Sara Samadzadeh

Zitieren

APA

Hefter, H., & Samadzadeh, S. (2026). Patient Perceptions of a Preventive Effect of Long-Term Botulinum Neurotoxin Therapy in Cervical Dystonia. Toxins, 18(4), 184. https://doi.org/10.3390/toxins18040184

Vancouver

Hefter H, Samadzadeh S. Patient Perceptions of a Preventive Effect of Long-Term Botulinum Neurotoxin Therapy in Cervical Dystonia. Toxins. 2026;18(4):184. doi:10.3390/toxins18040184

BibTeX
@article{Hefter2026,
  author = {Hefter, Harald and Samadzadeh, Sara},
  title = {Patient Perceptions of a Preventive Effect of Long-Term Botulinum Neurotoxin Therapy in Cervical Dystonia},
  journal = {Toxins},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {184},
  doi = {10.3390/toxins18040184}
}
Kostenlos starten →